Where available up to 10y CAGR shown for absolute numbers
10y Average marked A shown for relative numbers such as margins
Fiscal
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Average (A)
Fiscal period end dates
Expand all rows
01Earnings per share
Earnings per share = Net Income / Number of Shares Outstanding
0.1
-
0.7
1.4
1.8
1.3
2
1.9
1.4
1.5
0.8
20.1%
02Free cash flow per share
1
0.6
1.6
2
2.4
1.6
2.1
1.9
3.1
3.3
3.1
12.2%
03Dividends per share
-
-
28.5
34
45
51.5
57.5
69
86
97.7
107.5
-
04Dividends payout, %
1.8%
19.5%
43.4%
24.8%
1.3%
39.3%
28.6%
35.2%
60%
62.5%
1.3%
(3.2)%
PROFIT AND LOSS STATEMENT
05Revenue
56.2
57.3
71.4
77.9
82.5
79.9
91.3
113.2
136.1
133.6
145.8
10%
06% Change
-
-
-
-
-
-
-
-
-
-
-
10%
07Cost of revenue
(24.8)
(24.2)
(29.8)
(30.8)
(68.1)
(69.8)
(75.9)
(92.2)
(42.5)
(41.6)
(133.1)
18.3%
08Gross profit
31.4
33.1
41.5
47.1
14.4
10
15.3
21
93.6
92
101
12.4%
09% Margin
55.9%
57.7%
58.2%
60.5%
17.4%
12.6%
16.8%
18.6%
68.8%
68.9%
69.3%
45.9% A
10Operating expenses
(29.7)
(32.1)
(35.9)
(36.5)
(37.4)
(0.1)
(0.1)
(0.1)
(72)
(75.3)
(88.2)
11.5%
11% of Revenue
(52.8)%
(56.1)%
(50.4)%
(46.8)%
(45.4)%
(0.1)%
(0.1)%
(0.1)%
(52.9)%
(56.4)%
(60.5)%
(38.3)% A
12Operating Income
2.3
1.7
5.9
10.7
14.4
10.2
15.6
18.2
21.6
16.7
12.8
18.6%
13Income tax expense
(0.1)
(0.3)
(0.4)
(1.1)
(1.8)
(0.8)
(2)
(3.2)
(3.5)
(2.2)
(2.9)
35.6%
14Net Income
0.8
0.1
4
8.5
11.4
8.2
12.7
12.5
9.5
10.4
5.5
21.7%
15% Margin
1.4%
0.1%
5.6%
10.9%
13.8%
10.3%
13.9%
11%
7%
7.8%
3.8%
7.8% A
16Shares Outstanding
6.2
6.2
6.2
6.3
6.3
6.4
6.4
6.4
6.6
6.7
6.8
0.9%
17EPS Basic
0.1
-
0.7
1.4
1.8
1.3
2
2
1.5
1.6
0.8
20.4%
18EPS Diluted
0.1
-
0.7
1.4
1.8
1.3
2
1.9
1.4
1.5
0.8
20.1%
19EBITDA
8.3
6.7
11
15
18.5
15.2
20.3
29
32.2
30.9
32.2
14.5%
% Margin
14.8%
11.8%
15.4%
19.3%
22.5%
19%
22.3%
25.6%
23.7%
23.1%
22.1%
20% A
20Net Interest Income (expense)
(0.6)
(0.6)
(0.5)
(0.5)
(0.5)
(0.7)
(0.8)
(4.4)
(7.1)
(3.8)
(3.6)
20.6%
21Net Debt / EBITDA
0.5
1.3
0.7
-
0.3
0.7
0.1
1.3
1.6
1.8
1.4
0.9 A
BALANCE SHEET
ASSETS
Current Assets
22Cash & equivalents
8.5
7.9
10.7
15.7
14.1
15.5
18.4
20.8
13.7
17.9
19.4
8.6%
23Short-term investments
-
-
-
-
-
-
-
-
-
-
-
-
24Accounts receivable
10.1
10.1
11.8
13.2
10.5
13
15.5
23.4
22.6
26.4
23.2
8.6%
25Other current assets
1.6
2.6
1.9
2.3
1.3
1.3
1.6
2.2
2.5
3.8
3.3
7.5%
26Inventory
7.9
9.9
10.4
10.5
12.5
12.6
14.1
22.3
26.5
28.1
24.8
12.1%
27Total Current Assets
27.5
29.2
32.9
39.5
38.5
42.4
49.7
68.7
65.3
76.2
70.7
9.9%
Non-Current Assets
28Net property, plant & equipment
4.8
5.3
5.3
5.5
10.5
11.8
12.4
20
26.4
31.8
33.5
21.5%
29Long-term investments
21.5
24
24.6
24.8
15
18.7
16.7
-
-
-
-
-
30Other non-current assets
(4.4)
(4.5)
(4.6)
(4.8)
6.6
9.1
10.1
97.1
91.8
97.1
83.9
-
31Total Non-Current Assets
21.9
24.8
25.3
25.5
32.1
39.6
39.3
117.1
118.2
128.9
117.4
18.3%
Total Assets
52.6
58.3
62.6
65.7
70.6
82
89
185.8
183.5
205.1
188.1
13.6%
LIABILITIES
Current Liabilities
32Accounts payable
5.4
5.3
4.4
5.4
5.5
5.9
6.4
8
7.2
7.3
24.5
16.3%
33Short-term debt
3.4
2.7
3.6
3.1
3.8
4.8
5.5
7.2
7.4
2.4
1.4
(8.4)%
34Other current liabilities
6.9
9.3
11
10.8
13.9
11.5
14.7
56.6
20.4
23.8
3.7
(6.1)%
35Total Current Liabilities
15.7
17.2
19
19.2
23.3
22.2
26.6
71.8
35
33.5
29.6
6.6%
Non-Current Liabilities
36Long-term debt
9.6
13.9
14.7
12
15.1
21.6
15.8
52.7
57.9
72.4
63.8
20.9%
37Other non-current liabilities
-
-
-
-
3.5
5.2
3.2
9
8
12
10.8
-
38Total Non-Current Liabilities
9.5
13.9
14.7
12
18.6
26.8
18.9
61.7
65.9
84.4
74.6
22.8%
39Total Liabilities
28.6
35.6
38
34.5
41.9
49
45.6
131.3
100.9
117.9
104.2
13.8%
SHAREHOLDERS` EQUITY
40Common stock
0.3
0.3
0.3
0.3
0.3
0.3
0.3
0.3
0.3
0.3
0.3
(0.2)%
41Retained earnings / (deficit)
6.5
4.4
6.7
13
12
15.4
25.8
36.6
37.5
40.9
37.5
19.1%
42Accumulated other comprehensive income / (loss)
-
0.2
0.1
0.2
0.1
-
-
0.1
26.9
26.5
(0.4)
-
43Noncontrolling interests
0.8
1.4
1.1
0.6
0.8
0.9
0.6
0.2
0.2
0.3
-
-
44Total shareholders' equity
24.1
22.7
24.7
31.2
28.7
33
43.4
54.5
82.6
87.2
83.7
13.3%
45Total Liabilities and shareholders' Equity
52.6
58.3
62.6
65.7
70.6
82
89
185.8
183.5
205.1
188.1
13.6%
46Total Debt
12.9
16.5
18.3
15
18.9
26.4
21.3
59.9
65.3
73.6
65.2
17.6%
47Net Debt
4.4
8.6
7.6
(0.7)
4.8
10.8
2.9
39.1
51.6
55.7
45.8
26.4%
CASH FLOW STATEMENT
CASH FLOWS FROM OPERATING ACTIVITIES
48Net income (loss)
0.8
0.1
4
8.5
11.4
8.2
12.7
12.5
9.5
10.4
5.5
21.7%
49Depreciation & amortization
6
5.7
5.3
4.4
4.4
5
4.8
11
15.4
13.8
19.4
12.4%
50Share-based compensation expense
0.1
0.2
0.3
0.3
0.3
0.3
0.6
0.7
1.2
1.3
1.4
28%
51Changes in working capital and other assets
(0.3)
(1.5)
0.9
0.1
0.5
(1.8)
(1.2)
(4)
0.4
3
0.1
-
52Net cash flows from operating activities
6.6
4.6
10.5
13.3
16.6
11.8
16.9
20.2
26.5
28.5
26.4
14.9%
CASH FLOWS FROM INVESTING ACTIVITIES
53Purchases of property, plant and equipment
(0.5)
(0.8)
(0.7)
(1)
(1.3)
(1.3)
(3.4)
(7.9)
(4.7)
(5)
(7.2)
29.8%
54Purchases of investments / marketable securities
-
-
-
-
-
-
-
-
-
-
-
-
55Proceeds from maturities of marketable securities
-
-
-
-
-
-
-
-
-
-
-
-
56Other investing activities
(7.5)
(6.4)
(7.1)
(0.5)
(0.1)
(11.4)
(1.8)
(42.9)
(21.2)
(17.6)
(0.2)
(30.4)%
57Net cash flows from investing activities
(8.1)
(7.2)
(7.8)
(1.5)
(1.4)
(12.7)
(5.2)
(50.8)
(25.9)
(22.6)
(7.4)
(0.8)%
CASH FLOWS FROM FINANCING ACTIVITIES
58Issuance (repurchases) of common stock, net
0.2
-
0.1
0.6
0.3
1
0.2
0.2
0.4
1.4
0.1
(4)%
59Dividends paid, net
(1.4)
(1.6)
(1.7)
(2.1)
(15.1)
(3.2)
(3.6)
(4.4)
(5.7)
(6.5)
(7.1)
17.8%
60Debt issuance (repayments), net
0.1
3.5
1.8
(3.2)
(0.6)
6.8
(4.2)
38.6
2.8
9.2
(8)
-
61Other financing activities
-
-
-
(2.2)
(1.3)
(2.2)
(1.2)
(3.2)
(5.1)
(5.5)
(2.4)
47.6%
62Net cash flows from financing activities
(1.2)
1.9
0.1
(6.8)
(16.8)
2.3
(8.8)
31.2
(7.6)
(1.4)
(17.4)
31.2%
63Increase (decrease) in cash and cash equivalents
(2.6)
(0.6)
2.8
5
(1.6)
1.4
2.9
2.4
(7.1)
4.2
1.5
-
64Cash and equivalents, ending balance
8.5
7.9
10.7
15.7
14.1
15.5
18.4
20.8
13.7
17.9
19.4
8.6%
65Free Cash Flow to the Firm (FCFF)
Free Cash Flow to the Firm = Cash Flows from Operating Activities - Capital Expenditures
6
3.8
9.8
12.4
15.3
10.5
13.4
12.3
21.8
23.5
19.2
12.3%
Judges Scientific N (JDG.L) financial statements and performance
Explore Judges Scientific N (JDG.L) annual and quarterly financial statements, including revenue, operating income, net income, cash flow, assets, liabilities, and per-share metrics.
Compare reporting periods and financial trends to evaluate profitability, balance-sheet strength, cash generation, and long-term business performance.